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Spermatogenesis is a complex process in which male germ cells undergo a mitotic phase
followed by meiosis and by a morphogenetic process to form mature spermatozoa. Sper-
matogenesis is under the control of gonadotropins, steroid hormones and it is modulated
by a complex network of autocrine and paracrine factors.These modulators ensure the cor-
rect progression of germ cell differentiation to form mature spermatozoa. Recently, it has
been pointed out the relevance of endocannabinoids as critical modulators of male repro-
duction. Endocannabinoids are natural lipids able to bind to cannabinoid receptors and
whose levels are regulated by specific biosynthetic and degradative enzymes. Together
with their receptors and metabolic enzymes, they form the “endocannabinoid system”
(ECS). In male reproductive tracts, they affect Sertoli cell activities, Leydig cell prolifera-
tion, germ cell differentiation, sperm motility, capacitation, and acrosome reaction. The
ECS interferes with the pituitary-gonadal axis, and an intricate crosstalk between ECS and
steroid hormones has been highlighted. This mini-review will focus on the involvement of
the ECS in the control of spermatogenesis and on the interaction between ECS and steroid
hormones.
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INTRODUCTION
Infertility affects 10–15% of couples, and it has been estimated that
a male factor is responsible in approximately half of these cases.
Male infertility is diagnosed with the analysis of several semen
parameters, such as the number of total sperm, sperm motil-
ity, and percentage of sperm cells with a normal morphology.
It is known that marijuana, the commonest recreational drug of
abuse, has adverse effects on male reproductive physiology. Its use
is associated with impotence, decreased testosterone plasma level,
impairment of spermatogenesis, production of spermatozoa with
abnormal morphology, reduction of sperm motility and viability
and, more recently, with the occurrence of non-seminoma germ
cell tumors (1). The identification of endogenous cannabinoids
(ECBs) that mimic some effects of delta-9-THC, the active prin-
ciple of Cannabis sativa, has opened new studies on the biological
role of ECBs in male reproduction. In this mini-review we focused
on the relevance of endocannabinoids and “endocannabinoid sys-
tem” (ECS) in spermatogenesis and sperm functions, and on the
interplay between ECS and sex hormone.
SPERMATOGENESIS
Spermatogenesis is a complex differentiative process starting from
spermatogonial stem cells (SSCs), known as A-single (As). The As
cells, similarly to other stem cells, have the capability to self-renew,
producing daughter As cells, and to progress into “undifferenti-
ated spermatogonia”known as A-paired (Apr), and A-aligned (Aal)
that represent committed cells. The Aal spermatogonia then differ-
entiate into A1-4, intermediate (In) and B spermatogonia which
undergo meiosis as pre-leptotene spermatocytes (2). Spermato-
cytes pass sequentially through leptotene, zygotene, pachytene,
and diplotene phases of prophase I, and then quickly undergo
two M-phase divisions, yielding haploid spermatids, that became
spermatozoa through the morphogenetic process called spermio-
genesis. Sperm released from the seminiferous epithelium into the
tubule lumen are still immature and are not able to fertilize an egg.
Sperm maturation occur in the epididymis. During spermatogen-
esis, germ cells, at each stage of differentiation, are in close contact
with Sertoli cells which provide physical and metabolic support for
their proliferation, meiosis, and successful progression into sper-
matozoa. Sertoli cells proliferate quickly during perinatal period
and they switch to a mature, non-proliferative state, around the
onset of puberty. Since only a limited number of germ cells can
be supported by each Sertoli cell (3), in adult testis, the number of
Sertoli cells will be a critical factor with obvious consequences on
fertility.
Spermatogenesis continues throughout life and it is regu-
lated by a complex assortment of hormones as well as numerous
locally produced factors that include growth factors, cytokines,
and chemokines, that act through autocrine and paracrine path-
ways. Sertoli cell-secreted growth factors are known to have direct
effects mainly on spermatogonia: Gdnf acts on self-renewal of
SSCs and inhibits their differentiation (4), Bmp4 has both a pro-
liferative and differentiative effect on these cells (5), and Kit Ligand
(KL), acts on the kit tyrosine-kinase receptor expressed by differ-
entiating type A spermatogonia (6) stimulating their progression
into the mitotic cell cycle and reducing apoptosis (7). The major
hormonal control system of spermatogenesis is the hypothalamic-
pituitary-gonadal axis, based essentially on the release of two
gonadotropins, luteinizing hormone (LH) and follicle stimulating
hormone (FSH), under the stimulation of hypothalamic GnRHs.
Leydig and Sertoli cells, the somatic cells of the testis, are pri-
mary responders to circulating gonadotropin hormones and their
failure to respond appropriately, results in male infertility (8). LH
stimulates Leydig cells to synthesize testosterone (T) and FSH acts
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on Sertoli cells stimulating their proliferation and expression of
several trophic factors essential for spermatogenesis.
THE ENDOCANNABINOID SYSTEM
Endocannabinoids are lipid-signal molecules that are endogenous
ligands for cannabinoid receptors, and together with enzymes
responsible for their synthesis and degradation, they form the
“ECS” (9). ECS is conserved from invertebrate to mammals
and it assumes important role in physiological and patholog-
ical processes. The two best characterized endocannabinoids
are N -arachidonoyl ethanolamine (AEA, anandamide) and 2
arachidonoyl glycerol (2-AG).
Endogenous cannabinoids bind to and activate their target
receptors, causing several biological effects on different tissues.
The main cannabinoid receptor targets type-1 (CB1) and type-
2 (CB2) are seven trans-membrane G protein-coupled receptors
(10). CB1 is widely expressed in the nervous system mainly at
the terminal ends of central and peripheral neurons, but it is
also expressed in ovary, uterus, testis, vas deferens, and urinary
bladder. CB2 is mainly expressed in the cells of the immune sys-
tem but it is also found in brainstem (11). ECBs are released
from membrane phospholipid precursors by specific phospho-
lipases, that are activated “on demand.” AEA synthesis is catalyzed
by an N -acylphosphatidylethanolamine-specific phospholipase D
(NAPE-PLD) (12). Similarly, the formation of 2-AG involves a
rapid hydrolysis of inositol phospholipids by a specific phospho-
lipase C (PLC) to generate diacylglycerol (DAG), which is then
converted into 2-AG by an sn-1-DAG lipase (DAGL) (13). As
lipid molecules, ECBs diffuse passively through the membrane,
but the presence of a membrane transporter, EMT, that acts by a
facilitated diffusion mechanism, has been hypothesized (14, 15).
More recently an anandamide transporter named FLAT, which
facilitates its translocation into cells has been identified in neural
cells (16). The biological effects of ECBs depend on their lifes-
pan in the extracellular space, which is limited by a re-uptake
by cells. Once inside the cells ECBs are hydrolyzed by two spe-
cific enzymes: the fatty acid amide hydrolase (FAAH) cleaves AEA
into arachidonic acid and ethanolamine, and the monoacylglyc-
erol lipase (MAGL) (17) transforms the 2-AG into arachidonic
acid and glycerol (18).
AEA, but not 2-AG, behaves also as an endovanilloid binding to
the type-1 vanilloid receptor (transient receptor potential vanilloid
1, TRPV1) at an intracellular site (19). TRPV1 is a six trans-
membrane spanning non-selective cation channel, whose expres-
sion is found mainly in specialized sensory neurons that detect
painful stimuli (20). However it is now established that TRPV1
is expressed also in non-neuronal cells, such as keratinocytes and
epithelial and endothelial cells, where it could play a wide variety
of physiological functions.
THE ENDOCANNABINOID SYSTEM AND SPERMATOGENESIS
ECS AND GERM CELLS
Following the discovery of ECS, many studies about its expression
and function in male reproductive system have been carried out
(21). The presence of components of ECS has been demonstrated
in the testis, in the reproductive fluids and tracts, in different
organisms from invertebrates to mammals. All the components
of the ECS have been identified in mammalian germ cells, from
spermatogonia to spermatozoa.
First evidence of an effect of cannabinoid in male reproduction
comes from a study in sea urchin in which it was demonstrated
that exogenous cannabinoid THC directly reduced the fertilizing
capacity of sperm (22) through the inhibition of the acrosome
reaction (23). Next, endogenous cannabinoid AEA was shown to
induce the same effects of THC on sea urchin sperm (24).
Endocannabinoids have been identified in human seminal
plasma (25), in the amphibian cloacal fluid (26) and in mouse
epididymis (27) indicating a role in the control of sperm func-
tions. Most of the in vitro studies reported an adverse effect of
AEA on sperm function with inhibition of motility, capacitation
and acrosome reaction, and indicated a pivotal role of CB1 receptor
in mediating AEA effects. In humans, AEA inhibits sperm motility
by decreasing mitochondrial activity and this effect was blocked by
the CB1 receptor antagonist SR141716 (28). In boar (Sus scropha),
a stable AEA analog, methanandamide, reduces sperm capaci-
tation and inhibits acrosome reaction (29). Also in frog Rana
esculenta AEA has been shown to inhibit sperm motility through
CB1 receptor (26).
It has been described a role of CB1 in spermiogenesis, when
elongated spermatids are remodeled to form mature spermato-
zoa with a change in the chromatin structure. Indeed, genetic
inactivation of CB1 causes an inefficient histone displacement,
poor chromatin condensation, and DNA damage in sperm (30),
indicating a role of ECS in spermatid differentiation.
Further interesting findings supporting a role of AEA and CB1
receptor on sperm function arise from the gene knockout animal
models. In the absence of CB1 signaling, sperm acquire motility
precociously and the percentage of motile spermatozoa recovered
from the caput of epididymis was higher with respect to wild-type
mice, suggesting a physiological inhibitory regulation of endo-
cannabinoids on sperm motility in the epididymis (31). Genetic
loss of FAAH results in increased levels of AEA in the reproductive
system and impairment of sperm fertilizing ability (32). These
results lead to hypothesize that an “adequate tone” of AEA and
the expression of CB1 receptor are critical in the formation of
morphologically and functionally normal sperm. In support of
this observation, it has been recently reported that, in rats, in vivo
administration of HU210, a synthetic analog of THC and a potent
agonist of CB receptors, causes a marked impairment of spermato-
genesis with reduction in total sperm count and motility, and
a deregulation of the ECS, confirming the in vitro observations
and indicating that the use of exo-cannabinoids may influence
adversely male fertility (33).
Another molecular target of AEA is the vanilloid receptor
TRPV1 (34), expressed in sperm cells of mouse (35), boar (29),
bull (36), and humans (37). Activation of TRPV1 receptor by AEA,
seems to play a role in the stabilization of the plasma membranes in
capacitated boar sperm, preventing spontaneous acrosome reac-
tion (29). Therefore,AEA can bring different signals in sperm cells,
depending on the target receptor (CB1 or TRPV1) that is activated.
Besides AEA, also the endocannabinoid 2-AG has been reported
to affect male reproduction. Using mouse male germ cell popula-
tions at different stage of differentiation we highlighted a pivotal
role of 2-AG and CB2 receptor in mouse spermatogenesis (35).
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We demonstrated that mammalian male germ cells, from mitotic
to haploid stage, have a complete ECS which is modulated dur-
ing spermatogenesis. Spermatogonia possess higher level of 2-AG
that decreases in spermatocytes and drastically drops in sper-
matids. This correlates to higher level of biosynthetic (DAGL) and
lower level of degrading enzymes (MAGL) in spermatogonia with
respect to spermatocytes and spermatids. On the contrary, AEA
levels remain unchanged during spermatogenesis and probably
are crucial to maintain, locally, an appropriate “anandamide tone”
for a correct progression of spermatogenesis as seen for normal
development of mouse embryos (38). Interestingly, activation of
CB2 receptor in spermatogonia promotes their progression into
meiosis as revealed by an increased number of cells positive for
the meiotic marker SCP3 and by the expression of premeiotic and
early meiotic genes. Thus, during spermatogenesis an autocrine
endocannabinoid regulation of mitotic germ cell differentiation
might occur as proposed in Figure 1.
Endocannabinoid 2-AG has been also found to play a role in
regulating the ability of spermatozoa to become motile during
their transit in the epididymis. 2-AG levels are high in mouse sper-
matozoa isolated from the caput of the epididymis, where they
do not move regularly, and decrease dramatically in spermato-
zoa isolated from the cauda, where they acquire vigorous motility,
suggesting that, along the epididymis, the decrease of 2-AG lev-
els from caput to cauda promotes start-up of spermatozoa (27).
Finally mouse sperm capacitation has been found to be linked to
an enhancement of the endogenous tone of both AEA and 2-AG
(39), underlying the important role of ECS in regulating important
step of spermatogenesis and sperm functions.
With the aim to investigate, in humans, a possible relation-
ship between male reproductive dysfunction and deregulation of
the ECS, recent studies have shown a marked reduction of AEA
and 2-AG content in the seminal plasma of infertile patients. This
reduction in sperm from infertile versus fertile men can be deter-
mined by either an increased ratio of degradation/biosynthesis,
or by lower levels of CB1 mRNA expression (40, 41), indicating
that the ECBs signaling is involved in the preservation of normal
human sperm function.
ECS AND TESTICULAR SOMATIC CELLS
Endocannabinoid system components are expressed also in
somatic cells of mammalian testis. Sertoli cells possess the
biochemical machinery to synthesize, transport, degrade, and bind
both AEA (42) and 2-AG (43). Mouse Sertoli cells express a
functional CB2 receptor, an AEA membrane transporter and the
AEA-degrading enzyme FAAH (42). AEA has been shown to have a
pro-apoptotic effect on Sertoli cells, inducing DNA fragmentation.
Lower level of AEA correlates with higher level of FAAH protein
and with a decrease in Sertoli cell apoptosis, suggesting a protective
and pro-survival role of FAAH in Sertoli cells. More interest-
ingly, FAAH activity and expression is hormonally up-regulated
in Sertoli cells by FSH and estrogen (43, 44).
Rat Leydig cells express CB1 which is modulated during devel-
opment and it negatively correlates to cell division. Immature
Leydig cells in mitosis were negative for CB1, while immature
non-mitotic Leydig cells were positive, indicating a negative effect
of CB1 on Leydig cell proliferation and suggesting that their
differentiation may depend on the ECS (45).
THE ENDOCANNABINOID SYSTEM AND SEX HORMONE
As described above, the ECS is widely distributed in testicular
cells and it is an important regulator of spermatogenesis and
sperm functions. Recently, many evidence indicate the existence of
interplay between ECS and sex hormones, testosterone and estro-
gen, thus stressing the relevant role of ECS in regulating male
reproduction. Testosterone is produced by Leydig cells under the
stimulation of LH and it is essential for the occurrence of events
like blood-testis-barrier formation, germ cells progression beyond
meiosis, mature sperm release. Sertoli cells are the major cellular
target for the testosterone signaling and the absence of testosterone
or of the androgen receptor, results in the failure of spermato-
genesis and infertility. Several studies on human males smoking
cannabis, reported a decrease in plasma levels of testosterone, FSH,
and LH and this effect was also evident in animal studies after
acute and chronic administration of THC (46, 47). Decreased lev-
els of testosterone correlate to an inhibitory effect of cannabinoids
on male sexual behavior (48). Moreover in vitro studies on Ley-
dig cells showed a decrease in testosterone secretion induced by
THC (49). Similarly endogenous cannabinoid AEA suppresses LH
and testosterone levels in wild-type, but not in CB1 knockout mice
(50), providing evidence that the ECS acts to suppress testosterone
levels.
It is now well documented that, beside testosterone, also estro-
gens are important modulator of male reproduction (51). The
FIGURE 1 | Effect of CB2 activation on the early steps of spermatogenic
differentiation. Mitotic male germ cells express CB2 receptor and high level
of 2-AG. Activation of CB2 receptor by 2-AG, through an autocrine pathway,
promotes meiotic entry and progression of spermatogonia, as revealed by the
meiotic organization of nuclear SCP3 (green) during the prophase I phases
(leptotene, zygotene, pachytene).
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FIGURE 2 | Regulation of AEA-degrading enzyme FAAH expression
by estrogen in Sertoli cells. E2 regulates FAAH transcription by direct
binding of estrogen receptor (ER) and epigenetic mechanisms including
histone modification and DNA methylation. On the left: in the absence of
estrogens, faah proximal promoter is methylated at DNA CpG sites and
at lysine 9 of H3 histone and it is not competent for transcription. The
final outcome is an increase AEA-induced apoptosis of Sertoli cells. On
the right: estrogens activates the AEA-degrading enzyme FAAH
transcription, through ER binding at ERE sites and reduction of DNA and
H3K9me3 methylation. The direct/indirect interaction with histone
demethylase LSD1, constitutively recruited at this site, is necessary for
estrogen-induced transcription. The final outcome is a decrease of
AEA-induced apoptosis of Sertoli cells (ERE, estrogen response
element).
presence of estrogens in male reproductive tracts of numerous
mammals has been reported (52). Aromatase is the enzyme that
converts irreversibly androgen into estrogens and is expressed, in
mammals, in all testicular cells except peritubular cells. The bio-
logical effects of estrogens are mediated by the estrogen receptorsα
(ERα) and β (ERβ), both expressed in mammalian testis. A role of
estrogens in spermatogenesis is strongly supported by the observa-
tion that mice lacking estrogen receptors or aromatase are infertile
and show impaired spermatogenesis in adulthood (53, 54).
Between all the components of ECS, the AEA-degrading
enzyme faah gene has been demonstrated to be the only gene
to be hormonally regulated in the testis. In Sertoli cells, FSH regu-
lates FAAH expression and activity by triggering protein kinase A
or aromatase-dependent pathway (42).
The PKA-dependent pathway enhances FAAH activity by
inducing phosphorylation of other proteins that could activate the
enzyme. On the other hand, the aromatase-dependent pathway,
that leads to the conversion of testosterone into estrogens, induces
FAAH expression at transcriptional level. Indeed we recently clar-
ify the molecular mechanisms by which estrogens directly up-
regulate faah gene transcription (55). This involves direct binding
of ER to the ERE sites in the faah promoter and the induc-
tion of epigenetic modifications in order to confer transcriptional
competence.
As presented in Figure 2, in Sertoli cells, E2 engages ER, which
binds to ERE sites in the faah proximal promoter determining
demethylation of both DNA, at CpG site, and histone H3, at lysine
9 (H3K9). The presence of histone demethylase LSD1, which is
recruited at this site, ensures estrogens stimulation of faah tran-
scription. LSD1 could interact with ligand-bound ER or with other
different partners and activate gene transcription. The biologi-
cal relevance of E2-stimulation of FAAH expression consists in
decreasing AEA levels in Sertoli cells and protect them against
apoptosis induced by AEA. The pro-survival role of E2 in Sertoli
cells has a clear impact on spermatogenesis. In fact regulation of
Sertoli cell apoptosis could be important to maintain their popu-
lation size, and consequently, to sustain a normal spermatogenic
output.
This is not the only example about the cross-talks between
estrogens and ECS in the testis. Recent evidences reveal that estro-
gens affect spermiogenesis and regulate chromatin remodeling
of germ cells (56). Indeed, in mice, genetic loss of CB1 receptor
causes a reduction in FSH and estrogen plasma levels and alter-
ation in spermatid differentiation due to an inefficient histone
displacement in the sperm. Estrogens treatment is able to rescue
histone displacement suggesting a role in preserving chromatin
condensation in spermatozoa.
CONCLUDING REMARKS
In this mini-review we highlighted the physiological role of ECS
and its interplay with sex hormones, in male reproduction. A
full comprehension of the molecular events regulated by ECS
in the testis will allow to better define the “protective” role of
this system in maintaining and ensuring the correct progression
of spermatogenesis and the formation of mature and fertilizing
sperm. Interfering with this system by exposure to exogenous
cannabinoids, may alter the physiological function of ECS in male
reproduction thus affecting male fertility.
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